Danone is expanding into GLP-1 nutrition with dairy, microbiome solutions, and plant-based shakes. Three key moves shaping its strategy.

2025.10.30 by CHEN Yang China’s Innovent Biologics said its dual receptor agonist Mastutide delivered stronger results than Novo Nordisk’s semaglutide (Ozempic) in a Phase III

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by

In a large real-world Italian cohort, GLP-1 receptor agonist therapy led to measurable rates of type 2 diabetes remission, depending on how remission was defined.

Patients will be able to access Eli Lilly’s weight-loss drug Zepbound at Walmart pharmacies nationwide through its direct-to-consumer program as soon as next month.  The

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by

Post Content

Here’s what not to say—and how not to say it.

Comments

Food Funct., 2025, Advance ArticleDOI: 10.1039/D5FO03273C, Review Article Yingzhe Luo, Huimin Xu, Yaqin Zhao, Biao Yang, Ying ZhangGLP-1 receptor agonists modulate tumor metabolism and immunity

In October, GLP-1 manufacturers inked partnerships with big-box retailers to increase access as several studies indicate a low adherence rate for the expensive medications.  Three

(MedPage Today) — Thus far in 2025, notable developments in retinal disease have included several newsworthy associations with the widely used GLP-1 agonist drugs for

Superfruit specialist Fruitist has closed $150 million in equity financing led by a vehicle managed by J.P. Morgan Asset Management alongside other new and existing

Eli Lilly is making another move to help boost production for its oral GLP-1 franchise, with a new $1.2 billion factory in Puerto Rico. Construction

Eli Lilly and Walmart have partnered to offer in-store pickup of Zepbound (tirzepatide) single-dose vials through the LillyDirect platform by mid-November. The collaboration marks the

The obesity rate in the U.S. has seen a marked decline over the last three years, as the share of Americans who report using GLP-1

Eli Lilly LLY has been on an acquisition spree since the beginning of this year to bolster its pipeline, which should drive long-term growth. Although

An obesity medicine specialist’s thoughts on reducing the burden of prior authorization, documentation, and follow-ups. Medscape Medical News

Rise and shine, everyone, another busy day is on the way. And given that this is the middle of the week, it may be a

De novo GLP-1RAs can be computationally designed to exhibit extended half-life and superior efficacy compared to Semaglutide. Abstract Peptide drugs have revolutionized modern therapeutics, offering

Some seven million Americans are now on GLP-1 weight loss drugs, a figure expected to rise to 24 million by 2035. These medications curb users’

Key Points BioAge Labs is developing a promising weight management candidate. The medicine could have several advantages over approved anti-obesity drugs. However, BioAge is an

Abstract Aims To investigate the renal outcomes of dipeptidyl peptidase 4 (DPP-4) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and sodium-glucose transport protein-2 (SGLT-2) inhibitors in

Abstract Aims Acquired hypothalamic obesity (aHO) following craniopharyngioma (CP) is a challenging condition with limited therapeutic options. This study aimed to assess the real-world effectiveness

The idea was beautifully simple. One pill taken daily to melt away those excess pounds. The new breed of GLP-1 oral medications would be as

Eli Lilly and Company (NYSE:LLY) is included among the 10 Best Rising Dividend Stocks to Buy Now. Eli Lilly and Company (NYSE:LLY) is seen as

It’s been nearly three years since Withings first showed off U-Scan to a bemused world, and now it’s finally on sale. U-Scan is the company’s

The comedian has shed ‘at least 40lbs’ with help from GLP-1 weight loss drug Mounjaro.

Obesity rate is declining as more Americans use weight loss drugs, survey finds  CBS News Obesity Rate Declining in U.S.  Gallup News Weight loss drugs are bringing

For most of my adult life, I’ve felt helpless about being overweight. When I met with a doctor a few years ago to discuss my

Despite recent setbacks in court, Eli Lilly is doubling down on its fight against compounded weight loss drugs. The pharma giant told Endpoints News on

Gallup: Obesity Rate Declining in U.S.  —  Use of GLP-1 injectables for weight loss has more than doubled since early 2024  —  WASHINGTON, D.C. —

(MedPage Today) — The obesity rate for adults in the U.S. dropped to 37% in 2025 after peaking at 39.9% in 2022, but diabetes has

Shutterstock Modern medicine can do some amazing things, and has saved the lives of countless millions of people. There are, however, some drawbacks to most

Eli Lilly announced a partnership with chipmaker NVIDIA on Tuesday to build what it claims will be the “most powerful supercomputer owned and operated by

Texas Attorney General Ken Paxton is suing the pharmaceutical companies behind Tylenol for “deceptively marketing” the medication as a safe option for pregnant mothers. The

The impact of pharma’s direct-to-patient efforts is getting clearer. When Lilly launched its LillyDirect program in January 2024, it wasn’t immediately clear how big the

Research has suggested the potential of GLP-1 medications for treating substance use disorders, including alcohol, opioids, nicotine, and psychostimulants.